Pharmtechnology

NCT05940909

Phase 1, Status unknown, 50 people, 11 Jul 2023

NCT05642845

Phase 1, Completed, 50 people, 8 Dec 2022

NCT03459911

Phase 1, Completed, 66 people, 9 Mar 2018